Eurocell plc
Eurocell plc Fundamental Analysis
Eurocell plc (ECELF) shows moderate financial fundamentals with a PE ratio of 12.85, profit margin of 2.38%, and ROE of 9.23%. The company generates $0.4B in annual revenue with strong year-over-year growth of 12.74%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 42.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ECELF's fundamental strength across five key dimensions:
Efficiency Score
WeakECELF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentECELF trades at attractive valuation levels.
Growth Score
ModerateECELF shows steady but slowing expansion.
Financial Health Score
ExcellentECELF maintains a strong and stable balance sheet.
Profitability Score
WeakECELF struggles to sustain strong margins.
Key Financial Metrics
Is ECELF Expensive or Cheap?
P/E Ratio
ECELF trades at 12.85 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, ECELF's PEG of 0.59 indicates potential undervaluation.
Price to Book
The market values Eurocell plc at 1.18 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.61 times EBITDA. This is generally considered low.
How Well Does ECELF Make Money?
Net Profit Margin
For every $100 in sales, Eurocell plc keeps $2.38 as profit after all expenses.
Operating Margin
Core operations generate 4.98 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $9.23 in profit for every $100 of shareholder equity.
ROA
Eurocell plc generates $3.34 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Eurocell plc produces operating cash flow of $46.78M, showing steady but balanced cash generation.
Free Cash Flow
Eurocell plc produces free cash flow of $34.64M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.35 in free cash annually.
FCF Yield
ECELF converts 28.82% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
12.85
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.59
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.18
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.30
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.99
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.53
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.09
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How ECELF Stacks Against Its Sector Peers
| Metric | ECELF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 12.85 | 25.96 | Better (Cheaper) |
| ROE | 9.23% | 1263.00% | Weak |
| Net Margin | 2.38% | -41827.00% (disorted) | Weak |
| Debt/Equity | 0.99 | 0.79 | Weak (High Leverage) |
| Current Ratio | 1.53 | 10.05 | Neutral |
| ROA | 3.34% | -1497918.00% (disorted) | Weak |
ECELF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Eurocell plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
68.07%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
568.76%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
-100.00%
Industry Style: Cyclical, Value, Infrastructure
Declining